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INTRODUCTION
The introduction of cyclosporine A (CsA) in organ trans-
plantation greatly improved graft survival but the clinical
utility of CsA has been limited by the frequent occurrence
of chronic nephrotoxicity, characterized by striped interstitial
fibrosis, tubular atrophy and progressive renal functional
impairment (1, 2). Because CsA is known to induce intense
afferent arteriolar vasoconstriction (3, 4), it has been presumed
that the above tubulointerstitial changes are the result of
chronic low grade ischemia. However recent studies showed
that CsA could be directly toxic to renal tubular cells with
site selective action on proximal tubule (5, 6).
Apoptosis, a distinct form of cell death, can serve as a molec-
ular selection process for normal development and various
disease processes (7-9) and has also been reported to occur in
chronic CsA nephrotoxicity animal model as well as in cul-
tured tubular cell upon CsA stimulation (10-12). It suggests
that apoptosis can be another possible pathogenetic mecha-
nism of chronic CsA nephrotoxicity, but the mechanism of
apoptosis in CsA nephrotoxicity remains poorly defined.
Fas (APO-1/CD95)/Fas ligand (FasL) system is the best
characterized system that can mediate apoptotic cell death
in many cell types and also expressed in renal tubular cells
(13-16).
The initiation of downstream signaling events in response
to Fas/FasL interaction requires a complex network of inter-
mediate signaling proteins interacting with the cytoplasmic
domain of receptors via the conserved death domain (17).
One of them is Fas-associating protein with death domain
(FADD) or MORT1 and the subsequent  results of the sig-
naling process is the activation of caspase 8 (FLICE/MACH),
followed by the activation of caspase 3 (CPP32/YAMA/
APOPAIN) with cleavage of several substrates like poly-ADP
ribose polymerase (PARP), lamin, and actin (17, 18).
Schelling et al. recently observed that upregulated tubular
cell Fas is responsible for tubular cell loss in chronic renal
failure. This finding suggests that Fas system-mediated
tubular cell apoptosis can also be the principal mechanism
of apoptosis in tubular atrophy in chronic CsA nephrotoxic-
ity (19).
-melanocyte stimulating hormone ( -MSH) is a proopi-
omelanocortin derivatives and is an endogenous cytokine
that suppresses the inflammation in various animal models
by way of its inhibitory action on proinflammatory cytokines
and chemoattractant chemokines (20-23). Recently, Chiao
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-Melanocyte Stimulating Hormone (MSH) Decreases Cyclosporine A
Induced Apoptosis in Cultured Human Proximal Tubular Cells
The pathogenesis of chronic cyclosporine A (CsA) nephrotoxicity has not been
elucidated, but apoptosis is thought to play an important role in CsA induced
tubular atrophy. Recently Fas-Fas ligand system mediated apoptosis has been
frequently reported in many epithelial cells as well as in T lymphocytes. We inves-
tigated the ability of CsA to induce apoptosis in cultured human proximal tubular
epithelial cells and also the effect of  -MSH on them. Fas, Fas ligand, and an
intracellular adaptor protein, Fas-associating protein with death domain (FADD)
expression, and poly-ADP ribose polymerase (PARP) cleavage were also stud-
ied. CsA induced apoptosis in cultured tubular epithelial cells demonstrated by
increased number of TUNEL positive cells and it was accompanied by a signifi-
cant increase in Fas mRNA and Fas ligand protein expressions. FADD and the
cleavage product of PARP also increased, indicating the activation of caspase. In
-MSH co-treated cells, apoptosis markedly decreased with downregulation of
Fas, Fas ligand and FADD expressions and also the cleavage product of PARP.
In conclusion, these data suggest that tubular cell apoptosis mediated by Fas
system may play a role in tubular atrophy in chronic CsA nephrotoxicity and pre-
treatment of  -MSH may have a some inhibitory effect on CsA induced tubular
cell apoptosis.
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et al. reported a beneficial effect of  -MSH in murine model
of ischemic acute renal failure (ARF) through an inhibition
of mouse chemokine KC and intercellular adhesion molecule-
1 (ICAM-1) expression that mediates the adherence of neu-
trophils to endothelium and the subsequent neutrophil infil-
tration (24). In addition, we have observed that tubular cell
apoptosis also significantly decreased in  -MSH treated
group in ischemic ARF rat model with concomitant decrease
in Fas/FasL protein expression and suggested that the bene-
ficial effects of  -MSH might be partially related to its in-
hibitory action on Fas/FasL system and apoptosis (25). 
The aim of this study was to examine the capacity of CsA to
induce apoptosis in cultured human proximal tubular cells
and also Fas/FasL expression with downstream signaling
molecule, FADD and PARP cleavage as a possible mechanism
of CsA induced apoptosis as well as the effect of  -MSH on
them.
MATERIALS AND METHODS
Cell culture and experimental conditions
HK-2 (human kidney-2) cells, an immortalized proximal
tubular epithelial cell line from normal adult human kidney
were obtained from American Tissue Culture Collection
(Rockville, MD, U.S.A.). Cells were grown in DMEM/F12
medium (Dulbeco’ s modified Eagle’ s medium: Nutrient
Mixture F12 (Ham) 1:1 ratio), GIBCO BRL (Life Technolo-
gy, Grand Island, NY, U.S.A.) supplemented with 5% heat-
inactivated fetal bovine serum, 100 U/mL penicillin, 100  g/
mL streptomycin, 2 mM L-glutamine, 5  g/mL transferrin
(GIBCO BRL), 5 ng/mL sodium selenite (Sigma Chemical
Co., St. Louis, MO, U.S.A.), 5 pg/mL T3, 5 ng/mL hydro-
cortisone, 5 pg/mL PGE1, and 10 ng/mL epidermal growth
factor (Sigma). For passage, confluent cells were washed
with PBS, and removed with Trypsin-EDTA (GIBCO BRL),
and plated in DMEM/F12 complete media. Cells in the 4th
through 6th passage were used. After incubating the cells
in serum and growth factor-free basal medium for 24 hr,
CsA (Novartis Pharmaceutical Ltd) in various concentrations
(500, 1,000, and 10,000 ng/mL) were added and incubated
for 24 hr.  -MSH (1  M) was added 1 hr prior to addition
of CsA (1,000 ng/mL). Identical volume of olive oil was
used as vehicle (V) and normal control cells (NC) were incu-
bated with medium alone. Two independent experiments
were performed in triplicate.
Reverse transcription-PCR
Total RNA was extracted from the cells by TRIZOL
(GIBCO BRL) according to the manufacturer’ s protocol.
RNA concentrations were determined using spectrophoto-
metric readings at A260. One microgram of RNA was reverse
transcribed at 42℃ for 60 min in a 25  L reaction mixture
with 5×first strand buffer, 10 mM dNTP, 20 U RNAsin,
and 500 U of Moloney murine leukemia virus reverse tran-
scriptase (Superscripts, GIBCO BRL, Grand Island, NY,
U.S.A.). First strand cDNA (1  L) was amplified using 2.5
U Taq polymerase (Perkin Elmer, Foster city, CA, U.S.A.) in
a 50  L reaction volume containing 0.4  M primer pair,
200  M dNTP, 10 mM Tris-HCl, 1.5 mM MgCl2, and 50
mM KCl. The sequences of primer for human Fas were:
sense, 5′ -TCTGTT CTGCTGTGTCTTGG-3′ ; antisense,
5′ -GGG TGGCTTT GTCTTCTTCT-3′ and human ribo-
somal protein L-19 as an internal standerd were: sense, 5′ -
AGCCTGTGACTGT CCATTCC-3′ antisense, 5′ -TTG-
GTCTTAGACCTGCG AGC-3′ . The amplifying condi-
tions were repeated for 36 cycles of the following: denatura-
tion for 60 sec at 94℃, annealing for 60 sec at 58℃, and
extension for 60 sec at 72℃. The PCR products were ana-
lyzed on a 1% agarose gel and stained with ethidium bro-
mide. The band densities were determined using a Digital
Imaging & Analysis System (Alpha Innotech Corp., San
Leandro, CA, U.S.A.). The ratios of Fas to L-19 PCR prod-
ucts were expressed as percent of control mean in each groups
and compared between normal control, CsA, and CsA+ -
MSH group. 
Western blot analysis 
Both adherent and nonadherent cells were washed with
PBS and then solubilized in 2×SDS sample buffer, and
then boiled for 10 min. The samples were initially analyzed
by 10% SDS-polyacrylamide gel electrophoresis and stained
with Coomassie blue to assure identical loading (Bio-Rad
Mini Protean II). Aliquots of each sample containing the
same amount of protein were resolved in a 10% SDS-poly-
acrylamide gel and transferred to polyvinylidine difluoride
(PVDF) membrane. After incubation in a blocking solution
[5% nonfat dry milk in PBST (0.05% Tween 20 in PBS)] at
room temperature for 1 hr, the membranes were washed
repeatedly with PBST (4×10 min), and then incubated
with primary antibodies in a blocking solution at 4℃ over-
night. After the washing, the membranes were reacted with
a secondary antibody conjugated with horseradish peroxi-
dase (anti-mouse IgG HRP, Santa Cruz Biotechnology, CA,
U.S.A.) at room temperature for 1 hr. The primary antibod-
ies used were: (1) 1:2,000 mouse anti-FasL IgG (Transduc-
tion Laboratories, Lexington, KY, U.S.A.), (2) 1:500 mouse
anti-FADD IgG (Transduction Laboratories), (3) 1:10,000
mouse anti-PARP monoclonal antibody (CLONTECH
Laboratories, Palo Alto, CA, U.S.A.). After washing in PBST
(8×10 min), the membranes were visualized using enhanced
chemiluminescence (ECL: Amersham, Arlington Heights,
IL, U.S.A.) and exposed to Kodak XAR5 film. The band
intensities were expressed as a percent of control mean and
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MSH groups using the Digital Imaging & Analysis System
(Alpha Innotech Corp., San Leandro, CA, U.S.A.).
Detection of apoptosis
DNA fragmentation was examined by using the TUNEL
method (ApoAlert
� DNA Fragmentation Assay Kit, CLO
NTECH Laboratories, Palo Alto, CA, U.S.A.). Adherent
cells, grown in coverslide in six well plate under the experi-
mental conditions as above, were washed with PBS and
fixed with 4% formaldehyde/PBS for 30 min at 4℃. After
the cell membrane were permeabilized with 0.2% Triton
X-100/PBS for 15 min at 4℃, cells were incubated with a
mixture of nucleotide and TdT enzyme for 60 min in a dark,
humidified incubator at 37℃. The reaction was terminated
with 2×SSC and washed with PBS. After the mounting of
glass slide, fluorescent nuclei were detected by fluorescein
filters (BH2: Olympus). TUNEL positive cells were counted
in 5×200 filelds and mean number was compared between
groups.
Statistical analysis
Results are presented as mean percentage±SEM of normal
control value from two independent experiments, each per-
formed in triplicate. Comparisons between the normal con-
trol and CsA stimulated groups, CsA and CsA+ -MSH
groups were done using independent sample t-test and a p-
value less than 0.05 was considered to be statistically signif-
icant.
RESULTS
CsA induced Fas mRNA expression in cultured human
proximal tubular cells
Fas/L-19 ratio increased from 100±7.2% in normal con-
trol group to 132.5±18.8%, 146.3±0.7%, 116.3±13.7
% in CsA 500, 1,000, 10,000 ng/mL treated groups, respec-
tively but this trend was not statistically significant except
CsA 1,000 ng/mL group (p=0.15, p<0.01, and p=0.32 respec-
tively). In  -MSH co-treated group, Fas/L-19 ratio decreased
to 60±8.7% of normal control and it was a statistically
significant decrease compared to CsA 1,000 ng/mL group
(p<0.01) (Fig. 1).
CsA induced Fas ligand protein expression in cultured
human proximal tubular cells
FasL protein was basally expressed in a low level in cul-
tured proximal tubular cells (100±10.1%) and the expres-
sion significantly increased by CsA stimulation (CsA 500, Fas
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Fig. 1. Semiquantitative RT-PCR for human Fas. Compared with
normal control group, CsA treatment upregulated Fas mRNA
expression in cultured human proximal tubular cells. In CsA
(1,000 ng/mL)+ -MSH treated group, Fas mRNA expression
significantly reduced. *p<0.05 compared with normal control
group, **p<0.05 compared with CsA 1,000 ng/mL group. 
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Fig. 2. Western blot for Fas ligand. CsA increased Fas ligand
protein expression in cultured human proximal tubular cells and
in CsA+ -MSH group, expression of Fas ligand protein decrea-
sed significantly. *p<0.05 compared with normal control group,
**p<0.05 compared with CsA 1,000 ng/mL group. 
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CsA 1,000, CsA 10,000 ng/mL: 204.4±21.5, 208.7±15.1,
184.7±14.2%; p<0.01, p<0.01, and p<0.01, respectively).
In  -MSH co-treated group, the expression decreased to
110.4±12.2% compared to CsA 1,000 ng/mL group (p<
0.01) (Fig. 2).
CsA induced FADD protein expression in cultured
human proximal tubular cells
FADD was also basally expressed in cultured proximal
tubular cell and upon CsA stimulation, the expression in-
creased significantly (CsA 500, CsA 1,000, CsA 10,000
ng/mL: 190.0±18.8, 186.8±7.5, 159.0±2.2%: p<0.01,
p<0.01, and p<0.01, respectively). In  -MSH co-treated
group, FADD expression decreased to 121.9±1.7% of that
of normal control compared to CsA 1,000 ng/mL treated
group (p<0.01) (Fig. 3).
CsA increased the cleavage product of PARP indicat-
ing the activation of caspase
Because Fas/FasL mediated apoptotic pathway results in
the activation of caspase with cleavage of many substrates
like PARP, lamin, and fodrin, we examined a cleavage of
PARP, a DNA repair enzyme that is mainly cleaved by cas-
pase 3. In a basal condition, PARP exists predominantly as
a 116 kDa, full-length peptide, but in CsA stimulated con-
dition, 89 kDa cleavage product increased indicating the
activation of caspase 3. In  -MSH co-treated group, the cleav-
age product decreased compared to CsA treated group. We
used TNF- , a well known proapoptotic cytokine, as a pos-
itive control (Fig. 4).
CsA increased apoptosis in cultured human proximal
tubular cells
Compared to normal control vehicle treated cells, the num-
ber of TUNEL positive cells increased in CsA treated cells,
but decreased in  -MSH co-treated cells (Fig. 5). Mean num-
ber of TUNEL positive cells per×200 field in CsA treated
cells signiticantly increased compared with in normal control
cells (p<0.05), and decreased significantly in  -MSH co-
treated group (p<0.05, vs CsA treated group) (normal con-
trol/CsA 1,000/mL/ -MSH CsA 1,000+ -MSH: 4.6±0.6/
15.7±0.9/7.2±0.6).
DISCUSSION
In the present study, we have demonstrated that CsA in-
duced apoptosis in cultured human proximal tubular cells.
The CsA concentrations (500-1,000 ng/mL) used in this
study were to represent the approximate concentration range
in in vivo kidney tissue, and thus a nephrotoxic in vitro model
simulating clinical setting (26). Apoptosis, a genetically
regulated form of cell death has been observed in various
renal diseases, e.g., ischemia-reperfusion injury, transplant
rejection (27, 28) as well as other conditions characterized
by progressive tubulointerstitial injury and glomeruloscle-
rosis (19). In chronic CsA nephrotoxicity model, increased
apoptosis of tubulointerstitial cells were also observed and it
correlated with pathologic findings such as tubular atrophy
and interstitial fibrosis (10, 11). The mechanism for this
increase in apoptosis is not clear, but considering the known
vasoconstrictive effect of CsA, chronic low grade ischemia is
thought to play a role. This observation is in line with the
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Fig. 3. Western blot for FADD. Compared to normal control group,
FADD expression increased significantly in CsA treated groups.
In CsA+ -MSH group, FADD expression decreased. *p<0.05
compared with normal control group, **p<0.05 compared with
CsA 1,000 ng/mL group. 
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Fig. 4. Western blot for poly-ADP ribose polymerase (PARP). The
89 kDa cleavage product increased in CsA group compared
with normal control group, indicating the activation of caspase. In
-MSH treated group, the cleavage product decreased. A proapop-
totic cytokine TNF- was used as a positive control.  
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data that apoptosis was augmented by angiotensin II (Ang
II) and decreased by nitric oxide (NO) (10), but using an in
vitro culture system, direct toxicity to tubular cells has also
been documented (12, 29). In this study, we could demon-
strate that apoptosis as assessed by DNA fragmentation appar-
ently increased in CsA treated cells. The capacity of CsA to
induce apoptosis in tubular cells may be clearly related to
tubular atrophy in chronic CsA nephrotoxicity, because even
very small increase in apoptosis can result in a very signifi-
cant loss of cells in vivo due to the relatively short half life
of apoptotic cells.
Although it is apparent that tubular cell apoptosis induced
by CsA contribute to its nephrotoxicity, the molecular path-
ways that lead to apoptosis is not clear. Fas/Apo-1/CD95, a
45 kDa transmembrane protein is the best characterized re-
ceptor superfamily that can trigger apoptosis in various cells
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Fig. 5. In situ end labelling of apoptosis (×200). Compared with normal control group in which there were few TUNEL positive apop-
totic cell, apoptosis increased in CsA treated group. In CsA+ -MSH treated group, apoptosis decreased markedly suggesting its
inhibitory effect on tubular cell apoptosis. (A) normal control, (B) CsA 1,000 ng/mL, (C) CsA 1,000 ng/mL+ -MSH (1  M). (D) mean
number of TUNEL positive cells in each group. Compared with normal control, TUNEL positive cells increased markedly in CsA 1,000
ng/mL treated group (*p<0.05), and TUNEL positive cells decreased significantly in  -MSH co-treated group compared with CsA
1,000 ng/mL treated group (**p<0.05 vs CsA 1,000 ng/mL treated group).
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and also expressed in renal tubular epithelial cells (14-16).
The ligand for Fas belongs to tumor necrosis factor (TNF)
superfamily and is also known to be expressed in renal tubu-
lar cells (13). Recently, Fas/FasL system mediated apoptosis
is reported to play an important role in endotoxemia induced
ARF and tubular atrophy in animal models of chronic renal
failure (19, 30). The possbile involvement of Fas system in
chronic CsA nephrotoxicity has also been suggested by Healy
et al. who demonstrated the increased Fas protein expres-
sion in a CsA stimulated condition (12). Ortiz et al. also sug-
gested a role for the autocrine activation of Fas system in
CsA nephrotoxicity by observing that CsA induced apopto-
sis decreased by inhibitor of caspase 8, an upstream effector
of death receptor mediated apoptosis (29). In this study, we
also observed the increase of Fas mRNA expression in CsA
group compared with that in control or vehicle group. FasL
and subsequently FADD, an intracellular adaptor protein
that binds to a conserved amino acid sequence known as
“death domain” on the cytoplasmic domain of Fas receptor,
also increased in CsA group. Interestingly, in high dose CsA
treated group (10,000 ng/mL), further increase in Fas, FasL,
and FADD expressions was not observed any more. This
result raises a possibility that in the setting of high dose CsA,
cell necrosis predominates rather than Fas system mediated
apoptosis. Healy et al. had also observed that in high dose
CsA group, membrane integrity decreased significantly
together with increased LDH release indicating cell necrosis
rather than apoptosis (12).
We also examined the cleavage of PARP, a nuclear protein
involved in DNA repair, mainly cleaved by caspase 3. Cas-
pase 3 (CPP32/Yama/Apopain) is regarded as one of the
central executioner molecule in apoptotic pathway and in
CsA treated group, we observed the increase in 89 kDa PARP
cleavage product indicating the activation of caspase. Previ-
ously, the role of caspase in CsA induced apoptosis has been
suggested by Ortiz et al. who demonstrated that caspase
inhibitor significantly decreased apoptosis (29).
In addition, we were interested in the ability of  -MSH
in decreasing Fas/FasL mediated apoptosis in tubular cells
because we had previously observed that tubular cell apop-
tosis significantly decreased in  -MSH treated group with a
concomitant decrease in Fas/FasL expression in ischemic ARF
rat model (25).  -MSH, an endogenous antiinflammatory
cytokine, has been known to reduce cellular infiltrations in
various inflammatory conditions such as rat model of arthri-
tis and liver injury from septic shock (20-23).  -MSH also
has been reported to have a beneficial effect in ischemia/
reperfusion injury through its inhibitory action on the mouse
chemokine KC and ICAM-1 messages and on the induction
of iNOS with a resultant decrease in peroxynitrate produc-
tion (24). In our previous study, intraperitoneally adminis-
tered  -MSH was also effective in attenuating the severity
of injury determined by biochemical and histological data.
In addition,  -MSH also decreased tubular cell apoptosis at
24 hr after reperfusion when the severity of injury peaked
with concomitant decrease in Fas/FasL expression (25). How-
ever, an increase of Fas/FasL expression can be secondary to
inflammatory cytokines produced by infiltrating neutrophils
or tubular cells, and downregulation of the expression in  -
MSH treated group could also be secondary epiphenomenon
due to decreased cytokine production. So with in vivo study,
it was difficult to distinguish between these two possibili-
ties.
But in the present study, using an in vitro culture system,
-MSH, administered 1 hr prior to the addition of CsA,
significantly reduced Fas/FasL and FADD protein expres-
sions as well as the cleavage of PARP, which was pararelled
by reduced DNA fragmentation. These results indicate that
-MSH has a direct inhibitory effect on death receptor medi-
ated apoptosis in tubular cells. The effect of  -MSH on apop-
tosis or Fas/Fas ligand expression has not been studied pre-
viously. And the possible role of  -MSH in inhibition of Fas/
FasL expression and apoptosis and the precise mechanism
thereof need further studies.
In conclusion, our data suggest that CsA induced tubular
cell apoptosis may play an important role in tubular cell loss
in chronic CsA nephrotoxicity and Fas/FasL system can be
an important mediator of CsA induced apoptosis.  -MSH, a
nonspecific antiinflammatory cytokine can be a potential
therapeutic agent for CsA nephrotoxicity through its inhibito-
ry effect on Fas/FasL expression and apoptosis.
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